These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 5923176
1. The role of sialic acid in the release of proteins from L1210 leukemia cells. Glick JL, Goldberg AR, Pardee AB. Cancer Res; 1966 Aug; 26(8):1774-7. PubMed ID: 5923176 [No Abstract] [Full Text] [Related]
2. Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment. Bekesi JG, St-Arneault G, Holland JF. Cancer Res; 1971 Dec; 31(12):2130-2. PubMed ID: 5120303 [No Abstract] [Full Text] [Related]
5. Release of protein bound sialic acid from fibrosarcoma cells after cis-dichlorodiammine platinum (II) treatment: the possible role in tumor regression. Sarna S, Bhola RK, Sodhi A. Pol J Pharmacol Pharm; 1988 Dec; 40(3):295-302. PubMed ID: 3241769 [Abstract] [Full Text] [Related]
7. Surface coat of plasma membrane of L-1210 lymphoid leukemia cells. A cytochemical study. Ban DD, Przełecka A. Folia Histochem Cytochem (Krakow); 1981 Dec; 19(1):3-10. PubMed ID: 7262700 [Abstract] [Full Text] [Related]
8. Effect of enzymatic removal of cell surface sialic acid on the adherence of Walker 256 tumor cells to mesothelial membrane. Cormack D. Cancer Res; 1970 May; 30(5):1459-66. PubMed ID: 5426949 [No Abstract] [Full Text] [Related]
9. Monitoring molecules of the plasma membrane: renewal of sialic acid-terminating receptors. Marcus PI, Schwartz VG. Wistar Inst Symp Monogr; 1968 May; 8():143-51. PubMed ID: 5664322 [No Abstract] [Full Text] [Related]
11. Role of sialic acid in potassium transport of L1210 leukaemia cells. Glick JL, Githens S. Nature; 1965 Oct 02; 208(5005):88. PubMed ID: 5895038 [No Abstract] [Full Text] [Related]
13. Phagocytosis and the sialic acid of the surface of polymorphonuclear leukocytes. Noseworthy J, Korchak H, Karnovsky ML. J Cell Physiol; 1972 Feb 02; 79(1):91-6. PubMed ID: 5009381 [No Abstract] [Full Text] [Related]
14. Characterization and use of neuraminidase-modified L1210 plasma membranes for protection against tumor growth. Brandt AE, Jameson AK, Pincus JH. Cancer Res; 1981 Aug 02; 41(8):3077-81. PubMed ID: 7248964 [Abstract] [Full Text] [Related]
16. Augmentation of the antibody forming cell response to neuraminidase-treated cells by myxoviruses. Russell PH. Immunology; 1981 Dec 02; 44(4):781-7. PubMed ID: 6274794 [Abstract] [Full Text] [Related]
17. Intracellular protein breakdown in the L1210 ascites leukemia. Pine MJ. Cancer Res; 1967 Mar 02; 27(3):522-5. PubMed ID: 6021507 [No Abstract] [Full Text] [Related]
19. Correspondence re: J. H. Pincus, A. K. Jameson, and A. E. Brandt. Immunotherapy of L1210 leukemia using neuraminidase-modified plasma membranes combined with chemotherapy. Cancer Res., 41: 3082-3086, 1981. Brandt AE. Cancer Res; 1982 Oct 02; 42(10):4263-4. PubMed ID: 7105020 [No Abstract] [Full Text] [Related]
20. Effects of benzohydroxamic acids on L1210 lymphoid leukemia cell nucleic acid metabolism. Hall IH, Taylor K, Izydore RA, Daniels DL. Pharmazie; 1998 Nov 02; 53(11):794-9. PubMed ID: 9853360 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]